Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
EBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome from Non-Controlling InterestsInterest & Investment IncomeNon Operating IncomeNon Operating Investment IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Roivant Sciences (ROIV) Non Operating Income (2020 - 2025)

Historic Non Operating Income for Roivant Sciences (ROIV) over the last 6 years, with Q4 2025 value amounting to $8.3 million.

  • Roivant Sciences' Non Operating Income rose 39623.58% to $8.3 million in Q4 2025 from the same period last year, while for Dec 2025 it was -$11.4 million, marking a year-over-year decrease of 9732.87%. This contributed to the annual value of -$112.4 million for FY2025, which is 10939.22% down from last year.
  • As of Q4 2025, Roivant Sciences' Non Operating Income stood at $8.3 million, which was up 39623.58% from -$5.7 million recorded in Q3 2025.
  • In the past 5 years, Roivant Sciences' Non Operating Income ranged from a high of $18.1 million in Q4 2022 and a low of -$11.2 million during Q2 2025
  • For the 5-year period, Roivant Sciences' Non Operating Income averaged around -$86400.0, with its median value being -$1.5 million (2024).
  • Data for Roivant Sciences' Non Operating Income shows a peak YoY increase of 63437.5% (in 2022) and a maximum YoY decrease of 90970.15% (in 2022) over the last 5 years.
  • Over the past 5 years, Roivant Sciences' Non Operating Income (Quarter) stood at $2.5 million in 2021, then surged by 634.38% to $18.1 million in 2022, then plummeted by 88.33% to $2.1 million in 2023, then plummeted by 233.33% to -$2.8 million in 2024, then surged by 396.24% to $8.3 million in 2025.
  • Its Non Operating Income was $8.3 million in Q4 2025, compared to -$5.7 million in Q3 2025 and -$11.2 million in Q2 2025.